Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
07 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/07/3111088/0/en/Immix-Biopharma-Announces-Accelerated-NEXICART-2-Clinical-Trial-Progress-in-relapsed-refractory-AL-Amyloidosis.html
06 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/06/3095161/0/en/Immix-Biopharma-Attends-FDA-CEO-Forum-in-Washington-DC.html
03 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/03/3093133/0/en/Immix-Biopharma-Announces-Primary-Endpoint-Met-in-positive-NXC-201-Interim-Results-Presented-at-ASCO-Enabling-Path-to-Best-in-Class-Therapy-for-relapsed-refractory-AL-Amyloidosis.html
23 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/23/3087484/0/en/Immix-Biopharma-Further-Expands-U-S-Clinical-Sites-for-relapsed-refractory-AL-Amyloidosis-Trial-NEXICART-2.html
22 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/22/3087082/0/en/Immix-Biopharma-Announces-Positive-Results-for-NXC-201-at-ASCO-Oral-Presentation-Enabling-Pathway-to-Best-in-Class-Therapy-for-relapsed-refractory-AL-Amyloidosis.html
21 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/21/3086145/0/en/Immix-Biopharma-to-Host-KOL-Event-to-Discuss-NXC-201-Clinical-Data-Presented-at-ASCO-2025-in-relapsed-refractory-AL-Amyloidosis.html
ABOUT THIS PAGE